BioSpace News Archive

Genetown

BTL Continues to Revolutionize Non-Invasive Aesthetics by Extending the Sculpting Power of EMSCULPT® to the Arms and Legs

BTL, the manufacturer behind the game-changing EMSCULPT technology, is continuing to raise the bar in aesthetics and non-invasive body shaping.

July 16, 2019
·
3 min read
Aspenti Health™ Partners with Northwestern Medical Center for Drugs of Abuse Testing

Aspenti Health™ will now provide confirmation urine toxicology testing for Northwestern Medical Center (NMC).

July 16, 2019
·
2 min read
Policy

Mass. Nurses Association Reports: Department of Public Health Finds Baystate Noble and Wing ICUs ‘Necessary for Preserving Access and Health’ Following Closure Hearings

Nurses, patients and advocates are also fighting to preserve Baystate mental health units in Greenfield, Palmer and Westfield

July 16, 2019
·
4 min read
Deals

Protagonist Therapeutics Reports Granting of Inducement Award - July 16, 2019

Protagonist Therapeutics, Inc. reported that on July 15, 2019, it issued an inducement award to Sarita Khanna, Ph.D., the Company’s recently hired Vice President of Biostatistics, in accordance with the terms of Dr.

July 16, 2019
·
2 min read
Policy

Altaire Pharmaceuticals, Inc. Issues Voluntary Recall Of Over-The-Counter Ophthalmic Products Sold By Natural Ophthalmics And TRP Company, Inc.

Altaire Pharmaceuticals, Inc., announces that it is voluntarily recalling the Over-the-Counter drug products and lots, within expiry, sold by Natural Ophthalmics and TRP Company, Inc.

July 16, 2019
·
4 min read
Policy

Pennsylvania legislation signed into law by Governor Wolf providing rural trauma center funding and optimizing trauma center placement

On July 2nd Governor Tom Wolf signed HB 786 into law.

July 16, 2019
·
1 min read
Drug Development

Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)

Mallinckrodt plc announced that it is permanently discontinuing its Phase 2B study designed to assess the efficacy and safety of Acthar® Gel as an investigational treatment for amyotrophic lateral sclerosis.

July 16, 2019
·
11 min read
Deals

UAVenture Capital Fund Invests in Automatic Eyeglass Prescription Technology

UAVenture Capital Fund announced its seventh portfolio investment and the second investment from Fund II.

July 16, 2019
·
2 min read
Business

Zynex Schedules 2019 Second Quarter Earnings

The Company expects to file its 2019 second quarter financial results on Wednesday, July 31, 2019.

July 16, 2019
·
2 min read
BioForest

exocad ChairsideCAD Recognized as a 2019 Best of Class Technology Award Winner

exocad GmbH, the dental industry’s leading provider of CAD Software, has been selected as a 2019 Cellerant Best of Class Technology Award recipient.

July 16, 2019
·
4 min read